Reversing Epigenetic Changes in Skin Aging to Enhance Longevity Across Various Ethnicities and Skin Types with a Dihydromyricetin-Enriched Serum: Findings from a Prospective Cohort Investigation - Summary - MDSpire

Reversing Epigenetic Changes in Skin Aging to Enhance Longevity Across Various Ethnicities and Skin Types with a Dihydromyricetin-Enriched Serum: Findings from a Prospective Cohort Investigation

  • By

  • Minyue Qi

  • Paula Pitta

  • Katrin Wegner

  • Boris Kristof

  • Yan Feng

  • Günter Raddatz

  • Manuel Rodríguez-Paredes

  • Julia Gallinger

  • Rungsima Wanitphakdeedecha

  • Marc Winnefeld

  • Lilia Guadanhim

  • Cheri Frey

  • Frank Lyko

  • Cassandra Falckenhayn

  • Elke Grönniger

  • April 25, 2026

  • 0 min

Share

Objective:

To investigate whether epigenetic mechanisms related to skin aging are conserved across diverse ethnicities and phototypes, and to evaluate the effects of dihydromyricetin (DHM) on reversing these changes.

Key Findings:
  • Epigenetic aging signatures are conserved across different ethnicities, suggesting a universal mechanism.
  • Topical application of DHM significantly reverses biological skin age, indicating its potential as an anti-aging treatment.
  • DHM improves visible and structural signs of aging, enhancing overall skin appearance.
Interpretation:

The study supports the hypothesis that epigenetic mechanisms of skin aging are universal across ethnicities, and that DHM can be an effective intervention for skin longevity.

Limitations:
  • The small sample size in the pilot study limits the generalizability of the findings.
  • The product-use study's demographic representation may not fully capture the diversity of skin aging across all ethnicities.
Conclusion:

Epigenetic rejuvenation using DHM presents a promising strategy for enhancing skin longevity across diverse ethnicities and phototypes, potentially transforming anti-aging interventions.

Original Source(s)

Reversing Epigenetic Changes in Skin Aging to Enhance Longevity Across Various Ethnicities and Skin Types with a Dihydromyricetin-Enriched Serum: Findings from a Prospective Cohort Investigation

  • by Minyue Qi, Paula Pitta, Katrin Wegner, Boris Kristof, Yan Feng, Günter Raddatz, Manuel Rodríguez-Paredes, Julia Gallinger, Rungsima Wanitphakdeedecha, Marc Winnefeld, Lilia Guadanhim, Cheri Frey, Frank Lyko, Cassandra Falckenhayn, Elke Grönniger

  • April 25, 2026

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

AOPT Plus Collagen May Ease Rosacea

Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks.

Assessment of Safety and Effectiveness of Combined Platelet-Rich Plasma and Hyaluronic Acid Therapy for Neck Rejuvenation in Thailand: A Prospective Investigation